Mankind Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 2,708.52 | 2,689.20 | 2,686.45 |
| Operating Expense | 1,685.80 | 1,937.86 | 1,915.59 |
| Net Profit | 713.61 | 448.88 | 458.90 |
| Net Profit Margin | 26.35% | 16.69% | 17.08% |
| Earning Per Share | 17.29 | 10.87 | 11.12 |
| EBIDTA | 1,110.30 | 816.49 | 802.67 |
| Effective Tax Rate | 15.84% | 16.18% | 12.65% |
Particulars
Mar 2026
Revenue2,708.52
Operating Expense1,685.80
Net Profit713.61
Net Profit Margin26.35
Earning Per Share17.29
EBIDTA1,110.30
Effective Tax Rate15.84
